Stocks›Healthcare›NRC

NRC

NRC Health

NasdaqResearch view

$19.57−3.83%

Sep 25 close · 1D EOD · Databento

HealthcareServices-Commercial Physical & Biological ResearchSmall-capSEC EDGAR FY 2025-12-31

What happened

Daily closes · dots are Wire stories

What’s next

Expected around late October, going by its own filing history. The company has not announced a date yet. Its matching report came Oct 27, 2025 and Oct 25, 2024, after the close.

Last report

Jul 28, 2026−18.08%

after the close

Last 4, next close

median 17.05% either way

up 1 of 4

Every report since 2022 →

DateEventSourceNext close

Jul 28Earnings release, after the close · 8-KSEC EDGARSEC EDGAR ↗−18.08%

Next close = the first close after the event against the close before it. Prior-session closes only; not a call, not advice.

Big days · last year

Daily closes · Databento EOD

17 big days: a close more than 5.64% from the one before, three times NRC’s median day (1.88%). On 0 of 17, its largest peers moved the same way at least half as far. We show what we hold, never a cause.

Shaded: since our stories began, May 26, 2026

17Sep 24, 2026
Sep 24, 2026Nothing in our recordNo NRC story, brief or results filing in our record that dayGroup +1.6% did not move with it
+1.6% did not move with itCRL +6.2 · IQV +2.7 · MEDP +0.6 · INCY −0.2
−5.66%
16Sep 3, 2026
Sep 3, 2026Nothing in our recordNo NRC story, brief or results filing in our record that dayGroup +0.3% did not move with it
+0.3% did not move with itIQV +3.0 · INCY −0.6 · CRL +0.5 · MEDP +0.1
+6.20%
15Jul 29, 2026
Jul 29, 2026ResultsThe first close after a results filing (SEC 8-K, Item 2.02)Group −0.1% did not move with it
−0.1% did not move with itMEDP +2.4 · CRL −2.3 · INCY −2.2 · IQV +1.9
−18.08%
14Jun 11, 2026
Jun 11, 2026Nothing in our recordNo NRC story, brief or results filing in our record that dayGroup +1.5% did not move with it
+1.5% did not move with itINCY +2.3 · MEDP +2.0 · CRL +0.9 · IQV −0.6
−11.70%
13Jun 10, 2026
Jun 10, 2026Nothing in our recordNo NRC story, brief or results filing in our record that dayGroup −1.1% did not move with it
−1.1% did not move with itIQV −2.2 · INCY +2.1 · CRL −1.9 · MEDP −0.2
+7.75%
12May 1, 2026
May 1, 2026Before our storiesGroup −0.3% did not move with it
−0.3% did not move with itINCY +1.7 · CRL −0.7 · IQV −0.4 · MEDP −0.3
+5.77%
11Mar 10, 2026
Mar 10, 2026Before our storiesGroup −3.4% did not move with it
−3.4% did not move with itCRL −5.4 · IQV −4.3 · MEDP −2.5 · INCY −1.1
+8.68%
10Mar 5, 2026
Mar 5, 2026Before our storiesGroup +0.6% did not move with it
+0.6% did not move with itINCY −1.6 · CRL +1.0 · MEDP +0.8 · IQV +0.3
+7.01%
9Feb 23, 2026
Feb 23, 2026Before our storiesGroup −2.0% did not move with it
−2.0% did not move with itCRL −3.2 · IQV −2.0 · MEDP −1.9 · INCY −0.5
−8.56%
8Feb 20, 2026
Feb 20, 2026Before our storiesGroup +0.6% did not move with it
+0.6% did not move with itCRL +2.9 · IQV −2.2 · MEDP +1.6 · INCY −0.4
+9.80%
7Feb 13, 2026
Feb 13, 2026Before our storiesGroup +1.0% did not move with it
+1.0% did not move with itMEDP +2.9 · CRL +1.6 · IQV −1.1 · INCY +0.3
−5.85%
6Feb 12, 2026
Feb 12, 2026Before our storiesGroup −3.1% did not move with it
−3.1% did not move with itIQV −4.7 · CRL −4.4 · INCY +1.9 · MEDP −1.9
−6.69%
5Feb 4, 2026
Feb 4, 2026Before our storiesGroup −0.3% did not move with it
−0.3% did not move with itINCY +1.7 · MEDP −1.2 · IQV −0.6 · CRL +0.1
−13.34%
4Feb 3, 2026
Feb 3, 2026ResultsThe first close after a results filing (SEC 8-K, Item 2.02)Group −4.4% did not move with it
−4.4% did not move with itIQV −11.9 · CRL −5.5 · MEDP −3.3 · INCY −1.7
−19.54%
3Feb 2, 2026
Feb 2, 2026Before our storiesGroup +1.1% did not move with it
+1.1% did not move with itINCY +2.6 · CRL +1.3 · MEDP +1.0 · IQV +0.5
+7.67%
2Nov 21, 2025
Nov 21, 2025Before our storiesGroup +2.2% did not move with it
+2.2% did not move with itIQV +3.6 · CRL +3.4 · MEDP +1.0 · INCY +0.3
+6.32%
1Oct 28, 2025
Oct 28, 2025ResultsThe first close after a results filing (SEC 8-K, Item 2.02)Group −2.1% did not move with it
−2.1% did not move with itCRL −3.8 · MEDP −2.7 · INCY −1.5 · IQV +0.3
+16.02%

A story on the same day is not a cause, and a group move is not proof either. Group: IQV, INCY, MEDP, CRL, the largest companies in NRC’s SEC industry; “the same way” means the same direction and at least half as far. Prior-session closes only; not a call, not advice.

The numbers · FY2025, filed

SEC EDGAR

Market cap$433M

Revenue$137.4M−4.00%

Net income$11.6M

EPS, diluted$50.00+4707.70%

Operating margin16.4%

Return on equity82.9%

Debt / equity5.65

All filed figures

Snapshot

SEC EDGAR · FY 2025-12-31

SectorHealthcare

Market Cap$432.9M

Enterprise Value$507.8M

Income$11.6M

Sales$137.4M

Book/sh$0.63

Cash/sh$0.19

Dividend TTM$0.52

Payout95%

Employees—

IPO—

Quick Ratio—

Current Ratio0.55

Debt/Eq5.65

EPS (ttm)$50.00

EPS this Y4707.7%

EPS past 3/5Y240.2%

Sales past 3/5Y-3.2%

EPS Y/Y TTM4707.7%

Sales Y/Y TTM-4.0%

Shs Outstand22.12M

ROA8.6%

ROE82.9%

ROIC16.5%

Gross Margin—

Oper. Margin16.4%

Profit Margin8.4%

Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.

Revenue by fiscal year

$148.0M

FY21

$151.6M

FY22

$148.6M

FY23

$143.1M

FY24

$137.4M

FY25

Operating leverage — margins

GrossOperatingNet

Financials, annual · income and cash flowSEC EDGAR · open ▸

Financials — annual

SEC EDGAR · last 5 FY · tap a row to explain it

USD	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$148.0M	$151.6M	$148.6M	$143.1M	$137.4M
Gross Profit	—	—	—	—	—
Operating Income	$50.3M	$46.5M	$40.0M	$35.2M	$22.6M
Net Income	$37.5M	$31.8M	$31.0M	$24.8M	$11.6M
Diluted EPS	$1.46	$1.27	$1.25	$1.04	$50.00
Operating Cash Flow	$46.3M	$36.3M	$38.1M	$34.6M	$26.4M
Free Cash Flow	$40.8M	$26.4M	$22.3M	$19.2M	$15.7M

Same industry

In the screener →

IQV$44.5B INCY$25.1B MEDP$17.3B CRL$14.0B ICLR$13.2B ABSI$1.7B OABI$670M MXCT$121M

Build basket with NRC Screener

Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.